ORITAVANCIN DIPHOSPHATE

ORITAVANCIN DIPHOSPHATE

Biochem/physiol Actions

Oritavancin is a lipoglycopeptide vancomycin analog with broad spectrum activity against gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and organisms resistant to vancomycin and other antibiotics such as linezolid and daptomycin. Oritavancin has multiple mechanisms of action, including inhibition of transglycosylation, inhibition of transpeptidation, and cell membrane interaction/disruption. Oritavancin also has a long half-life, allowing for a single intravenous dose of rather than the standard vacomycin treatment of twice-daily infusions for ten days.

Caution

category 1 skin sensitizer

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3575122 ORITAVANCIN DIPHOSPHATE white to beige 100 SIGMA-ALDRICH −20°C
£502.82 (exc VAT) per 25MG
-
+
3575123 ORITAVANCIN DIPHOSPHATE white to beige 100 SIGMA-ALDRICH −20°C
£140.68 (exc VAT) per 5MG
-
+